These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8665538)

  • 1. Aggravation of parkinsonian tremor by cisapride.
    Sempere AP; Duarte J; Cabezas C; Clavería LE; Coria F
    Clin Neuropharmacol; 1995 Feb; 18(1):76-8. PubMed ID: 8665538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.
    Wiseman LR; Faulds D
    Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.
    McCallum RW; Prakash C; Campoli-Richards DM; Goa KL
    Drugs; 1988 Dec; 36(6):652-81. PubMed ID: 3065057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parkinsonism induced or worsened by cisapride].
    Naito Y; Kuzuhara S
    Nihon Ronen Igakkai Zasshi; 1994 Nov; 31(11):899-902. PubMed ID: 7723193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of a new gastrointestinal prokinetic; pharmacology of cisapride].
    Van Nueten JM; Schuurkes JA
    J Pharm Belg; 1991; 46(1):17-22. PubMed ID: 2051298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
    Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the action of cisapride on the guinea-pig ileum mediated via 5-HT4 receptors?
    Meulemans AL; Schuurkes JA
    Eur J Pharmacol; 1992 Feb; 212(1):51-9. PubMed ID: 1555639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic profile of cisapride 20 mg after once- and twice-daily dosing.
    Zhou H; Herron J; Clyde C; Lee P; Mechlinski W; Pesco-Koplowitz L
    Clin Ther; 1998; 20(2):292-8. PubMed ID: 9589820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.
    Tack J; Coremans G; Janssens J
    Drug Saf; 1995 Jun; 12(6):384-92. PubMed ID: 8527013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisapride: a gastrointestinal prokinetic drug.
    Barone JA; Jessen LM; Colaizzi JL; Bierman RH
    Ann Pharmacother; 1994 Apr; 28(4):488-500. PubMed ID: 8038476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extrapyramidalism associated with the use of cisapride].
    Mariscal E; Sagalés M; Pedrol E; Pedrol E; Montull S
    Med Clin (Barc); 1998 Apr; 110(12):477-8. PubMed ID: 9611723
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisapride accelerates gastric emptying and mouth-to-caecum transit of a barium meal.
    Baeyens R; Reyntjens A; Verlinden M
    Eur J Clin Pharmacol; 1984; 27(3):315-8. PubMed ID: 6391936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F; Staub P; Hammer B; Guyot J; Miazza BM
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of cisapride in gastric ulcer. Results of a double-blind randomized trial versus ranitidine and versus cisapride plus ranitidine.
    Testoni PA; Bagnolo F; Buizza M; Masci E; Toti GL; Spinelli A; Manzi G
    J Clin Gastroenterol; 1993 Jul; 17(1):5-9. PubMed ID: 8409300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
    Gullikson GW; Loeffler RF; Viriña MA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial.
    Fumagalli I; Hammer B
    Scand J Gastroenterol; 1994 Jan; 29(1):33-7. PubMed ID: 8128175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchospasm associated with cisapride.
    Pillans P
    BMJ; 1995 Dec; 311(7018):1472. PubMed ID: 8520336
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastrointestinal motility stimulating drugs and 5-HT receptors on myenteric neurons.
    Nemeth PR; Gullikson GW
    Eur J Pharmacol; 1989 Aug; 166(3):387-91. PubMed ID: 2806367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.